CARDIAC INVOLVEMENT IN JUVENILE IDIOPATHIC ARTHRITIS

View at publisher Summarise with VIRAT
Authors: Murat Sürücü
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory childhood disorder that primarily affects the joints but can also involve extra-articular organ systems. JIA is characterized by onset before the age of 16 and may present with various clinical manifestations beyond chronic arthritis, including cardiovascular abnormalities. IA is classified into six distinct disease subtypes, which differ in their clinical, genetic, laboratory, and demographic characteristics. The systemic and polyarticular subtypes of JIA are particularly associated with cardiac involvement. Although cardiac manifestations are often subclinical, they represent an important source of morbidity and mortality. JIA can involve all cardiac structures, including the pericardium, myocardium, endocardium, coronary vessels, cardiac valves, and the conduction system. Similar to other rheumatologic disorders, cardiac involvement in JIA typically follows an insidious course. Pericarditis is the most common cardiac finding, occurring in up to one-third of patients with systemic-onset JIA. In contrast, myocarditis and valvular abnormalities are less frequent but potentially serious complications. Heart failure is a rare but serious complication in patients with JIA, typically resulting from chronic inflammation, autoimmune vasculitis, drug-induced cardiotoxicity, or myocardial fibrosis. In JIA, heart failure most commonly presents as diastolic dysfunction; however, systolic impairment may occur in patients with systemic-onset disease. Echocardiographic evaluations in children with JIA have demonstrated diastolic dysfunction characterized by reduced E/A ratios and decreased tissue Doppler velocities. In adults with a history of JIA, increased left ventricular wall thickness and impaired global longitudinal strain suggest early myocardial fibrosis. Chronic systemic inflammation promotes endothelial dysfunction and oxidative stress, which contribute to accelerated atherosclerotic changes even during clinically inactive disease phases. Furthermore, autonomic dysfunction evidenced by reduced heart rate variability and altered neuropeptide levels adds to the overall cardiovascular dysregulation. Early detection of cardiovascular involvement through echocardiography, cardiac MRI, and vascular assessments, combined with aggressive control of inflammation using biological therapies, is essential to prevent progressive cardiac damage and improve long-term outcomes in patients with JIA.Keywords: Juvenile idiopathic arthritis; Myocarditis; Pericarditis; Diastolic heart failure

Fields of Study & Subjects

Autoimmune and Inflammatory Disorders Research Kawasaki Disease and Coronary Complications Streptococcal Infections and Treatments

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
77–83
Publication date
1 January 2026
Language
EN
Document type
Book chapter